# Evaluating the Efficacy of a Late-Life Schizophrenia Integrated Care Pathway to Treat Acute Psychotic Symptoms

> **NCT02529163** · NA · UNKNOWN · sponsor: **Centre for Addiction and Mental Health** · enrollment: 24 (actual)

## Conditions studied

- Schizophrenia
- Schizoaffective Disorder

## Interventions

- **OTHER:** Late-life Schizophrenia ICP
- **OTHER:** Treatment as Usual

## Key facts

- **NCT ID:** NCT02529163
- **Lead sponsor:** Centre for Addiction and Mental Health
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2015-08
- **Primary completion:** 2017-12
- **Final completion:** 2019-07
- **Target enrollment:** 24 (ACTUAL)
- **Last updated:** 2018-08-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02529163

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02529163, "Evaluating the Efficacy of a Late-Life Schizophrenia Integrated Care Pathway to Treat Acute Psychotic Symptoms". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02529163. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*